The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making.
Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development.
We offer a complete suite of software solutions for any mass spectrometry proteomics application in industry or academic life sciences research.
Our kits and reagents for sample preparation, quantification and quality control empower researchers to apply cutting-edge proteomics in-house.
The appointment will support Biognosys’ transformation to a leading provider of protein insights for the development of new breakthrough[...]READ MORE
Biognosys’ leading discovery proteomics services to add depth to NeoGenomics’ multiomics solutions for biopharma clinical trials and[...]READ MORE
Data from Biognosys and its collaborators demonstrate the technological advances and utility of their proteomics platforms in oncology R&D and clinical[...]READ MORE
The TrueDiscovery™, TrueTarget™, and TrueSignature™ platforms provide an integrated suite of research services that reveal deep biological insights from early stage[...]READ MORE
Biognosys’ TrueSignature™ proteomics panels serve as pharmacodynamic readout for protein degradation in Kymera’s discovery and clinical trial[...]READ MORE
The new and improved service will offer unprecedented depth, precision, and throughput, quantifying up to 3,000 proteins in plasma or[...]READ MORE
The limited-time offer includes a choice of 6 free months of SpectroDive™, our software for targeted proteomics, OR 3 free months of Spectronaut™, our DIA analysis[...]READ MORE
With a depth of up to 13,000 proteins, Biognosys’ proprietary HRM™ technology now enables near-complete quantification of tissue proteomes. [...]READ MORE
Biognosys is the first global proteomics service provider that is GLP certified for preclinical studies and GCP compliant for clinical[...]READ MORE
A growing number of scientific publications have been using Biognosys' technology and tools in[...]READ MORE
The agreement with Thermo Fisher Scientific is providing life science researchers with comprehensive mass spectrometry solutions to gain deep proteomic insights at a large[...]READ MORE